Article thumbnail

Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study

By Yuhua Li, Jiaofeng Wang, Feng Jiang, Wenyao Lin and Wei Meng
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3264525
Provided by: PubMed Central

Suggested articles

Citations

  1. (2000). A: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology
  2. (1999). Abad A: A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancers.
  3. (1998). Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature
  4. (2010). An insertion/deletion polymorphism in the 3’ untranslated region of betatransducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun
  5. (2009). Anagnou NP, Nikiteas N: Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
  6. (1995). Apoptosis in the pathogenesis and treatment of disease. Science
  7. (1998). Cell suicide for beginners. Nature
  8. (2008). Correlation of -31G/C Polymorphisms of Survivin Promoter to Tumorigenesis of Gastric Carcinoma.
  9. (2000). CSLC: The diagnostic standards of HCC.Chinese.
  10. (2004). D: A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells.
  11. (1997). DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med
  12. (2009). Dysregulation of apoptosis in hepatocellular carcinoma cells.
  13. (2008). Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia. Leukemia Research
  14. (2001). Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy.
  15. (2002). Global cancer statistics,
  16. (2009). Hepatocellular carcinomaepidemiological trends and risk factors. Dig Dis
  17. (2008). JY: Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer
  18. (2002). Kaibara N: Quantitative analysis of apoptosisrelated gene express ion in hapatocellular carcinoma. Cancer
  19. (2003). Konturek PC: Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci
  20. (2001). KR: Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol
  21. (2004). Liu JR: Apoptosome dysfunction in human cancer. Apoptosis
  22. (2008). LQ: Expression and the clinical significance of survivin protein and β-catenin protein in primary hepatocellular carcinoma (HCC).
  23. (1999). Marchisio C: Survivin apoptosis:an interloper between cell death and cell proliferation in cancer. Lab Invest
  24. (1998). Reed JC: IAP-family protein surviving inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res
  25. (2007). S: Survivin gene expression in chronic liver disease and hepatocellular carcinoma. Hepatogastroenterology
  26. (2000). Survivin as a radioresistance factor in pancreatic cancer.
  27. (2003). Survivin study: what is the next wave.
  28. (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene
  29. (2001). Tanigawa N: Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis. Cancer
  30. (2001). The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc
  31. (2007). Veress G: Survivin promoter polymorphism and cervical carcinogenesis.
  32. (2009). Y: Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.